- 1、本文档共5页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Edaravone treatment of 25 cases of acute cerebral infarction
PAGE \* MERGEFORMAT 5
Edaravone treatment of 25 cases of acute cerebral infarction
[Abstract] Objective To observe the edaravone treatment of acute cerebral infarction and safety. Methods 50 patients with acute cerebral infarction were randomly divided into treatment group (25 cases) and control group (25 cases). The control group cis to Kang treatment. edaravone treatment group therapy. Results After treatment, group 2 scores were improved, but the treatment group improved more significantly, compared with the control group there was significant difference (P lt;0.05). Conclusions of edaravone for acute brain infarction can improve neurological function and safe.
[Keywords:] Cerebral infarction; acute disease; edaravone
Acute cerebral infarction with high mortality, high morbidity and a high incidence of other characteristics, the treatment goal is to reduce mortality and major morbidity, and promote recovery of neurological function and improve patient quality of life. Currently used for treatment of the disease more drugs, including agents of brain protection has made great achievements, our data show that the free radical scavengers, calcium channel blockers than the positive effect of brain protection [1]. our hospital in December 2008 ~ April 2009 applications edaravone treatment of acute cerebral infarction in 25 cases, results were satisfactory, are as follows.
1 Clinical data
1.1 General Information The information selected 50 patients are in line with the Chinese Medical Association 1995 Fourth National Cerebrovascular Disease Conference revised standard, and meet the following conditions: (1) the age of 80 years of age; (2) onset in 48 h or less; (3) the following blood pressure 200/100 mm Hg; (4) is check the head CT ruled out intracerebral hemorrhage; (5) except for renal dysfunction. randomly divided into 2 groups: treatment group 25 patients, 13 male and female 12 patients, aged 42 to 78 years, mean age 63.3 years. the control gro
您可能关注的文档
- Ebastine transfer factor treatment of chronic oral Urticaria.doc
- Eavesdropping scandal spread decoding hidden rules.doc
- EB virus infection and practitioners 'Fuxie'.doc
- EB virus-related New Progress in cancer research.doc
- EB virus LMP1 gene-targeted shRNA expression vector Comparative Study.doc
- eBay wrong bet-.doc
- Ebb Tide Win in Chernical - Pharmaceutical Industry 2004 Review and 2005 Trends.doc
- EBNA2 gene eukaryotic expression vector and expression of functional products.doc
- EBM titanium scaffold microstructure control and osteogenic cells cultured three-dimensional composite.doc
- Ebony on the 308 on the antibacterial activity of clinical isolates.doc
文档评论(0)